Integrated Quantitative Proteomic and Phosphoproteomic Systems Analysis
Functional Molecular State. Measured Directly.
Proteas Health delivers integrated quantitative proteomic and phosphoproteomic analysis designed for drug discovery and translational development. This workflow directly measures the functional protein state of primary human cells and tissues, capturing abundance, phosphorylation dynamics, and signaling network activity with systems-level resolution.
Rather than inferring pathway activity from transcript abundance or predefined affinity panels, this approach quantifies protein expression and post-translational modification state simultaneously, enabling direct resolution of target engagement, pathway modulation, and mechanistic response.
Engineered for structured development programs, the platform supports mechanistic validation, vulnerability mapping, and translational progression toward therapeutic or diagnostic decision-making.
Differentiating Capabilities
- Unbiased deep proteome coverage without predefined target constraints
- Parallel quantification of protein abundance and phosphorylation state
- Network-level kinase and pathway inference modeling
- Integration of quantitative outputs into translational validation workflows
- Experimental confirmation in matched primary human systems
Translational Impact
- Identify actionable signaling nodes beyond transcript-level screening
- Resolve functional pathway activation independent of RNA expression
- Define disease- or treatment-dependent signaling vulnerabilities
- Support mechanism-of-action confirmation in physiologically relevant systems
- Enable structured progression toward assay development or therapeutic prioritization
Performance Summary
Detailed analytical performance metrics, coverage depth, and reproducibility specifications are provided in the downloadable Technical Brief.